Literature DB >> 27505668

IDH1, Histone Methylation, and So Forth.

Virginie Penard-Lacronique1, Olivier A Bernard2.   

Abstract

IDH mutants cause aberrant DNA and histone methylation and contribute to hematological and neuronal malignancies. In this issue of Cancer Cell, Inoue et al. describe a potential specific effect of IDH1 mutations that reduces Atm expression via inhibition of H3K9 demethylases, which may represent a first step toward cellular transformation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27505668     DOI: 10.1016/j.ccell.2016.07.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  2 in total

Review 1.  Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies.

Authors:  Narendra Wajapeyee; Romi Gupta
Journal:  Cancer Res       Date:  2021-09-16       Impact factor: 12.701

2.  IDH1 mutation activates mTOR signaling pathway, promotes cell proliferation and invasion in glioma cells.

Authors:  Timucin Avsar; Tansu Bilge Kose; Muhammed Deniz Oksal; Gizem Turan; Turker Kilic
Journal:  Mol Biol Rep       Date:  2022-08-07       Impact factor: 2.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.